HOLLY WILLIAMS: Open Payments
NPI 1225301831 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,065 in 43 payments from 15 companies in 2025. Trend: 2023 $338 · 2024 $1,010 · 2025 $1,065
Food & beverage: $1,065
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 5 | $292 |
| Boston Scientific Corporation | 8 | $228 |
| Abbott Laboratories | 5 | $94 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $85 |
| Amgen Inc. | 4 | $62 |
| PFIZER INC. | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Kestra Medical Technology Services, Inc. | 2 | $44 |
| Teleflex LLC | 1 | $30 |
| Edwards Lifesciences Corporation | 1 | $28 |
Products named: AMVUTTRA, AVVIGO Guidance System, LifeVest, REPATHA, CARDIOMEMS, ELIQUIS, LEQVIO, Assure WCD.
Industry payments across IN — which companies pay providers there.
